Breaking News Instant updates and real-time market news.

IDRA

Idera Pharmaceuticals

$2.64

0.01 (0.38%)

07:38
09/30/19
09/30
07:38
09/30/19
07:38

Idera Pharmaceuticals announces initiation of ILLUMINATE-206 trial

Idera Pharmaceuticals announced the initiation of a phase 2 trial, ILLUMINATE-206 which will evaluate tilsotolimod, a toll-like receptor 9 agonist, in combination with nivolumab, a programmed death receptor-1 blocking antibody, and ipilimumab, a human cytotoxic T-lymphocyte antigen 4 blocking antibody for the treatment of solid tumors. The primary objective of this phase 2, open-label, global, study is to demonstrate efficacy. Secondary and exploratory objectives include safety, tolerability, immunogenicity and translational data evaluations. The initial cohort of the trial will be patients with immunotherapy-naive Microsatellite Stable Colorectal Cancer. The second planned cohort of ILLUMINATE-206 will focus on treating patients with anti-PD-1 refractory Squamous Cell Carcinoma of the Head and Neck, which will initiate in the fourth quarter of this year. The basis for this trial is supported by data generated from the ILLUMINATE-101 trial, which studied intratumoral tilsotolimod monotherapy in 45 evaluable patients with a variety of solid tumor types in which 33% achieved stable disease. Translational research in ILLUMINATE-101, demonstrated that tilsotolimod increased dendritic cell activation and upregulated MHC class II and IFN-alpha signaling which suggests improved antigen presentation. These findings are consistent with those observed in the ILLUMINATE-204 trial in anti-PD-1 refractory metastatic melanoma patients. Therefore, the mechanism of action for tilsotolimod may be tumor-type agnostic and potentially beneficial in combination with checkpoint modulation in a variety of tumor types.

IDRA Idera Pharmaceuticals
$2.64

0.01 (0.38%)

12/17/18
WEDB
12/17/18
NO CHANGE
Target $16
WEDB
Outperform
Wedbush 'positive' on Idera's Phase 2 study data
Wedbush analyst Robert Driscoll reiterated an Outperform rating and $16 price target on Idera Pharmaceuticals after the company updated results from the ongoing Phase 2 study of tilsotolimod plus ipilumumab in patients with PD-1 refractory melanoma. In a research note to investors, Driscoll says he remains "positive" on the study data, which he believe supports the ongoing Phase 3, and adds that ORR has tracked slightly lower than the previous data cut, but he believes 29.4% remains clinically meaningful with the potential to improve as tumor reductions continue to evolve over time.
03/07/19
WEDB
03/07/19
NO CHANGE
Target $7
WEDB
Outperform
Idera Pharmaceuticals price target lowered to $7 from $16 at Wedbush
Wedbush analyst Robert Driscoll lowered his price target for Idera Pharmaceuticals to $7 from $16 after he tweaked his market assumptions for tilosotolimod in refractory melanoma to be more conservative as the landscape evolves. The analyst continues to see tilsotolimod as a differentiated I-O asset that is being developed in a rational I-O clinical strategy, and reiterates an Outperform rating on the shares.
03/08/19
HCWC
03/08/19
NO CHANGE
Target $14
HCWC
Buy
Idera Pharmaceuticals price target lowered to $14 from $18 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for Idera Pharmaceuticals to $14 following this week's Q4 results and corporate update. The new target reflects additional dilution from the stock purchase agreement. The analyst keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

BA

Boeing

$371.18

4.71 (1.29%)

17:42
11/22/19
11/22
17:42
11/22/19
17:42
Periodicals
Canada agency: Official's email on 737 reflects working-level view, Reuters says »

Canadian regulator…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$231.32

-4.2 (-1.78%)

17:36
11/22/19
11/22
17:36
11/22/19
17:36
Hot Stocks
CACI awarded $112.53M Army contract modification »

CACI was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

AGO

Assured Guaranty

$48.65

-0.03 (-0.06%)

17:35
11/22/19
11/22
17:35
11/22/19
17:35
Hot Stocks
Assured Guaranty CIO buys 25.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$310.48

-1.4 (-0.45%)

, DIS

Disney

$148.25

1.34 (0.91%)

17:33
11/22/19
11/22
17:33
11/22/19
17:33
Periodicals
Netflix internal data shows company not hurt by Disney+, Bloomberg says »

Netflix's (NFLX)…

NFLX

Netflix

$310.48

-1.4 (-0.45%)

DIS

Disney

$148.25

1.34 (0.91%)

AAPL

Apple

$261.81

-0.23 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

OYST

Oyster Point Pharma

$14.84

0.64 (4.51%)

17:24
11/22/19
11/22
17:24
11/22/19
17:24
Hot Stocks
Oyster Point Pharma discloses 'positive' Phase 1 results for OC-01 nasal spray »

Oyster Point Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SACH

Sachem Capital

$4.21

(0.00%)

17:19
11/22/19
11/22
17:19
11/22/19
17:19
Hot Stocks
Sachem Capital co-CEO Villano steps down »

Sachem Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$57.63

-0.61 (-1.05%)

17:18
11/22/19
11/22
17:18
11/22/19
17:18
Hot Stocks
Intel board member Goetz buys $5.04M in stock »

Intel board member James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 23

    Jan

SWAV

ShockWave Medical

$38.00

0.18 (0.48%)

17:12
11/22/19
11/22
17:12
11/22/19
17:12
Hot Stocks
ShockWave Medical CEO sells 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAEX

SAExploration

$2.61

0.16 (6.53%)

17:01
11/22/19
11/22
17:01
11/22/19
17:01
Hot Stocks
SAExploration receives Nasdaq non-compliance letter »

SAExploration Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OFG

OFG Bancorp

$20.48

0.17 (0.84%)

17:00
11/22/19
11/22
17:00
11/22/19
17:00
Hot Stocks
OFG Bancorp buys 40K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$49.00

0.17 (0.35%)

, BTI

British American Tobacco

$38.15

-0.21 (-0.55%)

16:47
11/22/19
11/22
16:47
11/22/19
16:47
Periodicals
POTUS in favor of raising minimum vaping age to 21, MarketWatch says »

U.S. President Donald…

MO

Altria Group

$49.00

0.17 (0.35%)

BTI

British American Tobacco

$38.15

-0.21 (-0.55%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$82.39

-1.08 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

HIBB

Hibbett Sports

$28.64

3.57 (14.24%)

16:45
11/22/19
11/22
16:45
11/22/19
16:45
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

MSCI

MSCI

$257.97

2.295 (0.90%)

16:43
11/22/19
11/22
16:43
11/22/19
16:43
Hot Stocks
MSCI COO sells 6,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$39.53

0.54 (1.39%)

, VIA

Viacom

$26.06

-0.03 (-0.11%)

16:35
11/22/19
11/22
16:35
11/22/19
16:35
Hot Stocks
CBS to list ViacomCBS shares on Nasdaq following merger »

CBS Corporation (CBS)…

CBS

CBS

$39.53

0.54 (1.39%)

VIA

Viacom

$26.06

-0.03 (-0.11%)

VIAB

Viacom

$23.64

0.38 (1.63%)

ICE

IntercontinentalExchange

$93.70

-0.19 (-0.20%)

NDAQ

Nasdaq

$104.36

-0.31 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DIS

Disney

$148.25

1.34 (0.91%)

16:32
11/22/19
11/22
16:32
11/22/19
16:32
Periodicals
Disney sees 'Frozen 2' having possible $40M opening day, Bloomberg says »

Disney told Bloomberg it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRH

Blue Capital

$7.00

(0.00%)

16:31
11/22/19
11/22
16:31
11/22/19
16:31
Hot Stocks
Blue Capital declares special distribution of 57c per common share »

Blue Capital Reinsurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/22/19
11/22
16:30
11/22/19
16:30
Options
Preliminary option volume of 18.4M today »

Preliminary option volume…

STX

Seagate

$59.27

-0.21 (-0.35%)

16:24
11/22/19
11/22
16:24
11/22/19
16:24
Hot Stocks
Seagate chairman sells 90K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEL

American Equity

$29.12

0.155 (0.54%)

16:21
11/22/19
11/22
16:21
11/22/19
16:21
Hot Stocks
American Equity raises annual dividend 7% to 30c per share »

American Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/22/19
11/22
16:20
11/22/19
16:20
Options
Closing CBOE SPX and VIX Index summary for November 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$49.25

0.4 (0.82%)

16:18
11/22/19
11/22
16:18
11/22/19
16:18
Hot Stocks
Morgan Stanley's Rooney sells over 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 06

    Dec

TSLA

Tesla

$332.91

-21.91 (-6.18%)

, GPS

Gap

$16.92

0.7 (4.32%)

16:17
11/22/19
11/22
16:17
11/22/19
16:17
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks ended the session…

TSLA

Tesla

$332.91

-21.91 (-6.18%)

GPS

Gap

$16.92

0.7 (4.32%)

UBER

Uber

$29.57

0.11 (0.37%)

CVX

Chevron

$118.62

-0.18 (-0.15%)

LB

L Brands

$18.01

0.83 (4.83%)

JWN

Nordstrom

$37.96

3.67 (10.70%)

SPLK

Splunk

$140.52

13.72 (10.82%)

PSTG

Pure Storage

$16.85

-2.99 (-15.07%)

FL

Foot Locker

$40.24

-1.22 (-2.94%)

WSM

Williams-Sonoma

$67.44

-1.325 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 12

    Dec

  • 27

    Feb

  • 10

    Mar

  • 11

    Mar

KKR

KKR

$29.13

0.06 (0.21%)

16:17
11/22/19
11/22
16:17
11/22/19
16:17
Hot Stocks
FS Investments and KKR Credit Advisors get merger shareholder approval »

FS/KKR Advisor and KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/22/19
11/22
16:17
11/22/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$43.66

0.45 (1.04%)

16:16
11/22/19
11/22
16:16
11/22/19
16:16
Hot Stocks
Douglas Emmett acquires roughly 17% of existing unconsolidated real estate fund »

Douglas Emmett announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.